Less Ads, More Data, More Tools Register for FREE

Pin to quick picksImage Scan Holdings Regulatory News (IGE)

Share Price Information for Image Scan Holdings (IGE)

Share Price is delayed by 15 minutes
Get Live Data
2.20    0.45 (25.71%)
Bid:
2.10
Ask:
2.30
Spread: 0.20 (9.524%)
Market Cap: £3.01m
IGE Live PriceLast checked at - London Stock Exchange

Intraday Image Scan Holdings Share Chart

Pre-Close Trading Update

3 Nov 2021 07:00

RNS Number : 1185R
Image Scan Holdings PLC
03 November 2021
 

03/11/2021

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain

 

IMAGE SCAN HOLDINGS PLC

("Image Scan" or the "Company")

 

PRE-CLOSE TRADING UPDATE

 

Image Scan (AIM: IGE), the specialist supplier of X-ray screening systems to the security and industrial inspection markets provides a pre-close trading update of its unaudited results for the year ended 30 September 2021.

Key Points:

· Order bookings increased to £2.8m (2020: £2.4m)

· Sales fell to £2.9m following weak first half (2020: £3.5m).

· Gross margin increased to 53% (2020: 49%)

· Strong control of overheads, reduced 18% to £1.3m (2020: £1.6m)

· Reportable unaudited pre-tax trading profit of £189k (2020: £112k)

· Pre-tax trading profit (adjusted for capitalized R&D spend) £98k (2020: £112k)

· First orders for new cabinet X-ray systems

· First orders for government customers in the USA

· Period-end order book of £516k (2020: £633k)

· Strong year-end cash balance of £1.2m (2020: £1.4m)

 

The COVID-19 pandemic continued to impact activity, with foreign travel for trade shows, sales presentations and in-person customer service only starting to become possible at the very end of the period. Despite the challenges, the business traded throughout the pandemic and careful management of overheads allowed it to make a profit whilst continuing with its ambitious new product development programme.

New orders increased to £2.8m (2020: £2.4m) and included both sales of new products, such as the Axis-CXi cabinet X-ray system, and sales to new customers in new territories. Among the new customer sales, those to government agencies in the USA and Canada were particularly significant, as the Company has invested in developing these important markets. Following a weak first half, sales strengthened to reach £2.9m (2020: £3.5m) at year-end and included a 30-unit portable X-ray sale to an Asian government. Margins were strong at 53% (2020: 49%).

A significant decrease in overheads to £1.3m (2020: £1.6m) reflected lower travel costs caused by the COVID-19 pandemic, a reduction in trade show costs, and judicious use of the Government furlough scheme in quieter periods. This, together with the strong margins, led to an unaudited pre-tax trading profit, calculated on the same basis as the prior year, of £98k (2020: £112k).

Much of the product development effort to the Company is now focussed on development of new product ranges, such as cabinet and conveyor X-ray systems which are expected to generate new revenue streams for the business. The Company is therefore in a position to implement the policy of capitalising its new product development spend under IAS38 Intangible Assets. The adoption of this policy is expected to increase the reportable pre-tax profit for the year by £91k to £189k. 

Stock has continued to be tightly managed, although global disruption in supply chains for a variety of components and commodities has forced the Company to start buying critical items for stock as they become available. This has yet to significantly impact stock levels or delivery times but will continue to require careful management going forward. The Company finished the year with an order book of £516k (2020: £633k) and a healthy cash balance £1.2m (2020: £1.4m).

The new product development programme continued to make good progress and launches of both portable and conveyor X-ray systems are anticipated for early in FY 2022. The R&D team has delivered a new suite of measurement techniques to a key industrial customer, and it is hoped this will lead to wider adoption of our industrial inspection systems.

Image Scan's Chairman and Chief Executive, Bill Mawer, commented:

"The COVID-19 pandemic has continued to impact all aspects of the business. Launching a new product without being able to visit customers or attend trade shows has presented a considerable challenge, as has servicing our widely deployed industrial X-ray machines. However, first orders were received for the new product, our industrial service contracts have been delivered, and it is pleasing to report a profit for the second year in succession. Disruption to global supply chains remains a concern but, with more product launches planned for the new year, and a world that is starting to adjust to the presence of COVID-19, we retain our optimistic outlook for the future."

 

 

 

For further information on the Company, please visit: www.ish.co.uk and for further information on its products, please visit: www.3dx-ray.com

 

 

 

Enquiries:

 

Image Scan Holdings plc

William Mawer, Chairman and Chief Executive Officer

Sarah Atwell King, Finance Director and Company Secretary

Tel: +44 (0) 1509 817 400

ir@ish.co.uk

W H Ireland

Mike Coe/Sarah Mather (Corporate Finance)

 

Tel: +44 (0) 117 945 3470

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFSMFMEEFSEDF
Date   Source Headline
5th Jun 20269:45 amRNSContract Award
30th Apr 20267:00 amRNSInterim Results
25th Feb 20262:27 pmRNSResult of AGM
25th Feb 20267:00 amRNSAGM Statement
2nd Feb 20267:00 amRNSUpdate on Defence Contract with NP Aerospace
21st Jan 20261:31 pmRNSNotice of AGM and Posting of Annual Report
2nd Dec 20257:00 amRNSFinal Results
18th Nov 20257:00 amRNS-RContract Award
11th Nov 20257:00 amRNSNew Contract Award
4th Nov 20257:00 amRNSTrading Update
2nd Sep 202511:23 amRNSHolding(s) in Company
21st Aug 20257:00 amRNSTrading Update And New Contract Awards
20th May 20258:32 amRNSInterim Results
14th May 202511:55 amRNSHolding(s) in Company
26th Feb 20252:38 pmRNSResult of AGM
26th Feb 20257:00 amRNSAGM Statement
15th Jan 202510:48 amRNSNotice of AGM & Posting of Annual Report
3rd Dec 20247:00 amRNSFinal Results
23rd Oct 20247:00 amRNSTrading Update
16th Oct 20247:00 amRNSContract Award Update
4th Sep 20247:00 amRNSHolding(s) in Company
21st Aug 20247:00 amRNSHolding(s) in Company
7th Aug 20247:00 amRNSHolding(s) in Company
5th Aug 20247:00 amRNSHolding(s) in Company
24th Jul 20247:00 amRNSHolding(s) in Company
15th Jul 20247:00 amRNSChange of Adviser
4th Jul 20247:00 amRNSContract Award
12th Jun 20247:00 amRNSContract award worth over £350k
20th May 20244:33 pmRNSHolding(s) in Company
30th Apr 20247:00 amRNSInterim Results
29th Apr 20247:00 amRNSInitial c£300k order for new Portable X-Ray System
12th Mar 20247:00 amRNSLaunch of AXIS-CXi Cabinet with AI Software
28th Feb 20242:48 pmRNSResult of AGM
28th Feb 20247:00 amRNSTrading Statement
26th Jan 20241:50 pmRNSHolding(s) in Company
18th Jan 20241:28 pmRNSHolding(s) in Company
11th Jan 20243:06 pmRNSHolding(s) in Company
9th Jan 202412:46 pmRNSNotice of AGM & Posting of Annual Report
9th Jan 202412:00 pmRNSHolding(s) in Company
22nd Dec 20231:30 pmRNSHolding(s) in Company
12th Dec 20237:00 amRNSFinal Results
10th Oct 20237:00 amRNSTrading Update
11th Sep 20237:00 amRNS2023 orders to over 30 countries
4th Jul 20237:00 amRNSHolding(s) in Company
26th Apr 20237:00 amRNSInterim Results
13th Mar 20239:34 amRNSHolding(s) in Company
28th Feb 20233:03 pmRNSResult of AGM
28th Feb 20237:00 amRNSTrading Statement
10th Feb 20231:26 pmRNSHolding(s) in Company
26th Jan 202312:09 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.